4/A//SEC Filing
STAAB THOMAS R II 4/A
Accession 0001127602-19-035849
CIK 0000882796other
Filed
Dec 25, 7:00 PM ET
Accepted
Dec 26, 5:09 PM ET
Size
5.2 KB
Accession
0001127602-19-035849
Insider Transaction Report
Form 4/AAmended
STAAB THOMAS R II
Senior Vice President and CFO
Transactions
- Award
Emp. Stock Option (Right to Buy)
2019-12-17+127,000→ 127,000 totalExercise: $3.23From: 2020-12-17Exp: 2029-12-17→ Common Stock (127,000 underlying)
Footnotes (1)
- [F1]Annual Employee Option Grant becomes exercisable at the rate of 25% on each of the first, second, third and fourth anniversaries of the date of grant.
Documents
Issuer
BIOCRYST PHARMACEUTICALS INC
CIK 0000882796
Entity typeother
Related Parties
1- filerCIK 0001230708
Filing Metadata
- Form type
- 4/A
- Filed
- Dec 25, 7:00 PM ET
- Accepted
- Dec 26, 5:09 PM ET
- Size
- 5.2 KB